{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:18:37Z","timestamp":1777889917220,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmcl.2026.130642","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:13:15Z","timestamp":1774714395000},"page":"130642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth"],"prefix":"10.1016","volume":"137","author":[{"given":"Michael J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor T.","family":"Ronayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanner J.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Wittmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant W.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatram R.","family":"Mereddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130642_bb0005","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1038\/onc.2008.14","article-title":"Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation","volume":"27","author":"Tucker","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bmcl.2026.130642_bb0010","article-title":"Methionine aminopeptidase-2 is a pivotal regulator of vasculogenic mimicry","volume":"47","author":"Shimizu","year":"2022","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmcl.2026.130642_bb0015","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1021\/bi1005464","article-title":"Protein n-terminal processing: substrate specificity of escherichia coli and human methionine aminopeptidases","volume":"49","author":"Xiao","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2026.130642_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44862-7","article-title":"Methionine aminopeptidase 2 and its autoproteolysis product have different binding sites on the ribosome","volume":"15","author":"Klein","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2026.130642_bb0025","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.1021\/acs.jmedchem.9b01070","article-title":"Identification of methionine aminopeptidase-2 (MetAP-2) inhibitor m8891: a clinical compound for the treatment of cancer","volume":"62","author":"Heinrich","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130642_bb0030","unstructured":"Wang, J. et al. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res 63 http:\/\/aacrjournals.org\/cancerres\/article-pdf\/63\/22\/7861\/2509612\/zch02203007861.pdf (2003)."},{"key":"10.1016\/j.bmcl.2026.130642_bb0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/jnci\/djq457","article-title":"Effect of nitroxoline on angiogenesis and growth of human bladder cancer","volume":"102","author":"Shim","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bmcl.2026.130642_bb0040","doi-asserted-by":"crossref","unstructured":"Goya Grocin, A., Kallemeijn, W. W. & Tate, E. W. Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity. Trends Pharmacol Sci vol. 42 870\u2013882 Preprint at Doi: https:\/\/doi.org\/10.1016\/j.tips.2021.07.004 (2021).","DOI":"10.1016\/j.tips.2021.07.004"},{"key":"10.1016\/j.bmcl.2026.130642_bb0045","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bmcl.2026.130642_bb0050","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.molcel.2021.05.004","article-title":"Maintenance of organellar protein homeostasis by ER-associated degradation and related mechanisms","volume":"81","author":"Lemberg","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmcl.2026.130642_bb0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ncb2738","article-title":"ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death","volume":"15","author":"Han","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bmcl.2026.130642_bb0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.celrep.2017.04.042","article-title":"MTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4","volume":"19","author":"Park","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmcl.2026.130642_bb0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63326","article-title":"The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals","volume":"10","author":"Torrence","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bmcl.2026.130642_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-023-00589-1","article-title":"Lysosomes mediate the mitochondrial UPR via mTORC1-dependent ATF4 phosphorylation","volume":"9","author":"Li","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.bmcl.2026.130642_bb0075","doi-asserted-by":"crossref","unstructured":"Papareddy, P. et. al. Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer. Drug Discov Today 30, 8 (2025).","DOI":"10.1016\/j.drudis.2025.104419"},{"key":"10.1016\/j.bmcl.2026.130642_bb0080","first-page":"4","article-title":"Nitroxoline: repurposing its antimicrobial to antitumor application","volume":"66","author":"Mitrovic","year":"2019","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.bmcl.2026.130642_bb0085","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.tet.2013.01.017","article-title":"Selective deprotection of silyl ethers","volume":"69","author":"Crouch","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2026.130642_bb0090","doi-asserted-by":"crossref","unstructured":"Sosic, I., et. al. Cathepsin b inhibitors: further exploration of the nitroxoline core. Bioorg Med Chem Lett 28, 7 (2018).","DOI":"10.1016\/j.bmcl.2018.02.042"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:23:30Z","timestamp":1777613010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S0960894X26001095"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130642","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130642"}}